| pubmed-article:2765638 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2765638 | lifeskim:mentions | umls-concept:C0678236 | lld:lifeskim |
| pubmed-article:2765638 | lifeskim:mentions | umls-concept:C0033105 | lld:lifeskim |
| pubmed-article:2765638 | lifeskim:mentions | umls-concept:C0038951 | lld:lifeskim |
| pubmed-article:2765638 | lifeskim:mentions | umls-concept:C1707689 | lld:lifeskim |
| pubmed-article:2765638 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2765638 | pubmed:dateCreated | 1989-9-26 | lld:pubmed |
| pubmed-article:2765638 | pubmed:abstractText | Two-phase medical surveys, in which a large sample is assessed with an inexpensive screening instrument and a subsample is selected for a more thorough diagnostic evaluation, appear to have great merit in the epidemiologic study of certain rare disorders. We present the optimal design of two-phase surveys when resources are fixed and when 100% of those screened positive in the first phase must be included in the second-phase evaluation. We go on to examine the relative efficiency of this two-phase design compared to a single-phase design in which all resources are used in a survey that employs the diagnostic evaluation. Given information on the accuracy of the screen and the prevalence of the disorder, the utility of the two-phase design depends on the relative cost of the screening to the diagnostic assessments. | lld:pubmed |
| pubmed-article:2765638 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2765638 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2765638 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2765638 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2765638 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2765638 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2765638 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:2765638 | pubmed:issn | 0006-341X | lld:pubmed |
| pubmed-article:2765638 | pubmed:author | pubmed-author:ShroutP EPE | lld:pubmed |
| pubmed-article:2765638 | pubmed:author | pubmed-author:NewmanS CSC | lld:pubmed |
| pubmed-article:2765638 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2765638 | pubmed:volume | 45 | lld:pubmed |
| pubmed-article:2765638 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2765638 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2765638 | pubmed:pagination | 549-55 | lld:pubmed |
| pubmed-article:2765638 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:meshHeading | pubmed-meshheading:2765638-... | lld:pubmed |
| pubmed-article:2765638 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2765638 | pubmed:articleTitle | Design of two-phase prevalence surveys of rare disorders. | lld:pubmed |
| pubmed-article:2765638 | pubmed:affiliation | Division of Biostatistics, Columbia University School of Public Health, New York, New York 10032. | lld:pubmed |
| pubmed-article:2765638 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2765638 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2765638 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2765638 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2765638 | lld:pubmed |
